Patents by Inventor Kevin McKernan
Kevin McKernan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250034662Abstract: A method of detecting contamination in Psilocybe spores, Psilocybe tissue, or a cultured host organism that expresses Psilocybe genes may include obtaining a sample including nucleic acids from Psilocybe spores, Psilocybe tissue, or the cultured host organism that expresses Psilocybe genes; contacting the sample with primers for amplifying target nucleic acid sequences, amplifying any of the target nucleic acid sequences when present among the nucleic acids to obtain amplicons; and detecting the amplicons upon amplification of the target nucleic acid sequence. The primers may include primers for amplifying a bacterial target nucleic acid sequence, a Psilocybe target nucleic acid sequence, and/or a fungal target nucleic acid sequence. A kit for detecting contamination in Psilocybe spores, Psilocybe tissue, or a cultured host organism that expresses Psilocybe genes may include those primers and probes for detecting the amplicons amplified from any of those target nucleic acid sequences.Type: ApplicationFiled: December 1, 2022Publication date: January 30, 2025Applicant: MEDICINAL GENOMICS CORPORATIONInventor: Kevin MCKERNAN
-
Publication number: 20220369649Abstract: This invention generally relates to compositions comprising thaumatin-like proteins (TLP) and chitinases for use as laboratory reagents or biofungicides. The invention further relates to methods of detecting and inducing pathogen resistance in plants.Type: ApplicationFiled: November 5, 2020Publication date: November 24, 2022Inventors: Kevin McKernan, Biao Liu
-
Publication number: 20220017974Abstract: The present disclosure provides methods and kits for characterizing Cannabis plants. Methods and kits of the present disclosure include detection/amplification of one or more enzymes involved in the production of cannabinoids, such as, for example, tetrahydrocannabinolic acid (THCA) synthase and/or cannabidiolic acid (CBDA) synthase.Type: ApplicationFiled: June 14, 2021Publication date: January 20, 2022Applicant: MEDICINAL GENOMICS CORPORATIONInventor: Kevin MCKERNAN
-
Publication number: 20190323078Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: ApplicationFiled: May 7, 2019Publication date: October 24, 2019Inventors: Kevin McKernan, Alan BLANCHARD, Lev KOTLER, Gina COSTA
-
Patent number: 10323277Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads.Type: GrantFiled: October 12, 2016Date of Patent: June 18, 2019Assignee: APPLIED BIOSYSTEMS, LLCInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Publication number: 20180163253Abstract: Methods for producing a paired tag from a nucleic acid sequence are provided in which the paired tag comprises the 5? end tag and 3? end tag of the nucleic acid sequence. In one embodiment, the nucleic acid sequence comprises two restriction endonuclease recognition sites specific for a restriction endonuclease that cleaves the nucleic acid sequence distally to the restriction endonuclease recognition sites. In another embodiment, the nucleic acid sequence further comprises restriction endonuclease recognition sites specific for a rare cutting restriction endonuclease. Methods of using paired tags are also provided. In one embodiment, paired tags are used to characterize a nucleic acid sequence. In a particular embodiment, the nucleic acid sequence is a genome. In one embodiment, the characterization of a nucleic acid sequence is karyotyping. Alternatively, in another embodiment, the characterization of a nucleic acid sequence is mapping of the sequence.Type: ApplicationFiled: November 20, 2017Publication date: June 14, 2018Inventors: Douglas SMITH, Joel Malek, Kevin McKernan
-
Patent number: 9822395Abstract: Methods for producing a paired tag from a nucleic acid sequence are provided in which the paired tag comprises the 5? end tag and 3? end tag of the nucleic acid sequence. In one embodiment, the nucleic acid sequence comprises two restriction endonuclease recognition sites specific for a restriction endonuclease that cleaves the nucleic acid sequence distally to the restriction endonuclease recognition sites. In another embodiment, the nucleic acid sequence further comprises restriction endonuclease recognition sites specific for a rare cutting restriction endonuclease. Methods of using paired tags are also provided. In one embodiment, paired tags are used to characterize a nucleic acid sequence. In a particular embodiment, the nucleic acid sequence is a genome. In one embodiment, the characterization of a nucleic acid sequence is karyotyping. Alternatively, in another embodiment, the characterization of a nucleic acid sequence is mapping of the sequence.Type: GrantFiled: March 21, 2016Date of Patent: November 21, 2017Assignee: APPLIED BIOSYSTEMS, LLCInventors: Douglas Smith, Joel Malek, Kevin McKernan
-
Patent number: 9670545Abstract: The present disclosure provides methods and kits for treating and classifying individuals at risk of or suffering from a neurological and/or mitochondrial dysfunction or disorder. In general, the individuals are treated and/or classified based on the presence of a change-of-function mutation in nuclear DNA that encodes TNF receptor-associated protein 1 (TRAP1). Treatment involves the administration of a therapeutically effective amount of an antioxidant.Type: GrantFiled: June 11, 2014Date of Patent: June 6, 2017Assignee: Coutagen Life Sciences, Inc.Inventors: Kevin McKernan, Richard Boles
-
Publication number: 20170081717Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads.Type: ApplicationFiled: October 12, 2016Publication date: March 23, 2017Inventors: Kevin McKernan, Alan BLANCHARD, Lev KOTLER, Gina COSTA
-
Patent number: 9493830Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: GrantFiled: October 18, 2013Date of Patent: November 15, 2016Assignee: Applied Biosystems, LLCInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Publication number: 20160265034Abstract: Methods for producing a paired tag from a nucleic acid sequence are provided in which the paired tag comprises the 5? end tag and 3? end tag of the nucleic acid sequence. In one embodiment, the nucleic acid sequence comprises two restriction endonuclease recognition sites specific for a restriction endonuclease that cleaves the nucleic acid sequence distally to the restriction endonuclease recognition sites. In another embodiment, the nucleic acid sequence further comprises restriction endonuclease recognition sites specific for a rare cutting restriction endonuclease. Methods of using paired tags are also provided. In one embodiment, paired tags are used to characterize a nucleic acid sequence. In a particular embodiment, the nucleic acid sequence is a genome. In one embodiment, the characterization of a nucleic acid sequence is karyotyping. Alternatively, in another embodiment, the characterization of a nucleic acid sequence is mapping of the sequence.Type: ApplicationFiled: March 21, 2016Publication date: September 15, 2016Inventors: DOUGLAS SMITH, Joel Malek, Kevin McKernan
-
Publication number: 20160186264Abstract: The present disclosure provides methods and kits for treating and classifying individuals at risk of or suffering from a neurological and/or mitochondrial dysfunction or disorder. In general, the individuals are treated and/or classified based on the presence of a change-of-function mutation in nuclear DNA that encodes TNF receptor-associated protein 1 (TRAP1). Treatment involves the administration of a therapeutically effective amount of an antioxidant.Type: ApplicationFiled: June 11, 2014Publication date: June 30, 2016Inventors: Kevin McKernan, Richard Boles
-
Publication number: 20160177404Abstract: Using the efficiency of next generation sequencing, a draft de novo reference sequence for the Cannabis (C.) Sativa and C. Indica genomes has been generated as well as four full length contiguous sequences with homology to THCA and CBDA synthases and 10 partially homologous contigs with truncated ORFs. In particular aspects the invention is directed to an (one or more) isolated sequence (e.g., nucleic acid sequence, DNA, RNA, genomic sequence, polypeptide) of a Cannabis genome and uses thereof.Type: ApplicationFiled: March 27, 2015Publication date: June 23, 2016Inventor: Kevin McKernan
-
Patent number: 9217177Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: GrantFiled: January 9, 2013Date of Patent: December 22, 2015Assignee: APPLIED BIOSYSTEMS, LLCInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Publication number: 20140248610Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: ApplicationFiled: October 18, 2013Publication date: September 4, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Publication number: 20140243232Abstract: In some embodiments, the present teachings provide compositions, systems, methods and kits for reducing the complexity of nucleotide sequences in a nucleic acid sample comprising the steps: hybridizing a plurality of polynucleotide constructs to at least one blocker oligonucleotide and to at least one capture oligonucleotide, wherein the plurality of polynucleotide constructs include a plurality of polynucleotides each joined to at least one nucleic acid adaptor, wherein the at least one nucleic acid adaptor can hybridize to the at least one blocker oligonucleotide, and wherein the at least one capture oligonucleotide can hybridize to at least a portion of target polynucleotides that are a sub-population of the plurality of polynucleotides, so as to produce a capture duplex.Type: ApplicationFiled: July 13, 2012Publication date: August 28, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Gavin Meredith, Christopher Clouser, Tanya Sokolsky, Kimberly Mather, Kevin McKernan, Marie Callahan, Gary Bee
-
Publication number: 20140057251Abstract: Using the efficiency of next generation sequencing, a draft de novo reference sequence for the Cannabis (C.) Sativa and C. Indica genomes has been generated as well as four full length contiguous sequences with homology to THCA and CBDA synthases and 10 partially homologous contigs with truncated ORFs. In particular aspects the invention is directed to an (one or more) isolated sequence (e.g., nucleic acid sequence, DNA, RNA, genomic sequence, polypeptide) of a Cannabis genome and uses thereof.Type: ApplicationFiled: August 17, 2012Publication date: February 27, 2014Applicant: Medicinal Genomics CorporationInventor: Kevin McKernan
-
Patent number: 8431691Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads. The invention further provides sets of labeled probes containing phosphorothiolate linkages.Type: GrantFiled: July 21, 2008Date of Patent: April 30, 2013Assignee: Applied Biosystems LLCInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Patent number: 8329404Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: GrantFiled: March 2, 2012Date of Patent: December 11, 2012Assignee: Applied Biosystems LLCInventors: Kevin McKernan, Alan Blanchard, Lev Kotler, Gina Costa
-
Publication number: 20120191363Abstract: The present invention provides methods for determining a nucleic acid sequence by performing successive cycles of duplex extension along a single stranded template. The cycles comprise steps of extension, ligation, and, preferably, cleavage. In certain embodiments the methods make use of extension probes containing phosphorothiolate linkages and employ agents appropriate to cleave such linkages. The invention provides methods of determining information about a sequence using at least two distinguishably labeled probe families. In certain embodiments the methods acquire less than 2 bits of information from each of a plurality of nucleotides in the template in each cycle. In certain embodiments the sequencing reactions are performed on templates attached to immobilized beads. The invention further provides sets of labeled extension probes containing phosphorothiolate linkages.Type: ApplicationFiled: March 2, 2012Publication date: July 26, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: KEVIN MCKERNAN, ALAN BLANCHARD, LEV KOTLER, GINA COSTA